Profiles people listing in a scrolling container.
  1. Home
  2. Faculty

Lori Wallrath, PhD

Professor of Biochemistry and Molecular Biology

Introduction

Research in the Wallrath laboratory is centered on the role of chromatin packaging, nuclear organization, pre-mRNA processing and gene expression with respect to human disease. Currently, the focus is on two types of nuclear factors. (1) Lamins are filamentous proteins that form a meshwork underlying the inner nuclear membrane. The provide structural support for the nucleus and organize the genome in the nucleus. Mutations in the LMNA gene encoding A-type lamins cause a collection of diseases known as laminopathies that includes muscular dystrophies, adipose tissue disorders, and early onset aging syndromes. (2) SNRNP200 is a pre-mRNA splicing factor with RNA helicase activity that is a core component of the spliceosome. Mutations in SNRNP200 cause Retinitis Pigmentosa, a rare vision disorder. Members of the laboratory have developed Drosophila (fruit fly) models of these diseases that recapitulate many aspects of the human diseases. These models are being used to identify pathways altered by these mutations and perform genetic and pharmacological screens to identify potential therapies.

Current Positions

  • Professor of Biochemistry and Molecular Biology

Education

  • BS in Microbiology, Michigan State University, East Lansing, Michigan
  • PhD in Genetics, Michigan State University, East Lansing, Michigan
  • Postdoctoral Fellow in Chromatin Structure and Gene Expression, Washington University, St. Louis, Missouri

Graduate Program Affiliations

Selected Publications

  • Friedman TB, Owens KN, Burnett JB, Saura AO, Wallrath LL (1991). The faint band/interband region 28C2 to 28C4-5(-) of the Drosophila melanogaster salivary gland polytene chromosomes is rich in transcripts. Mol .Gen. Genet. 226: 81-87. DOI: 10.1007/BF00273590. PMID: 1903504
  • Mohar NP, Langland CJ, Darbro BW, Wallrath LL. SMAD7 is a modifier of LMNA-associated muscular dystrophy and a potential therapeutic target. (in revision)
  • Mohar NP, Cox EM, Adelizzi E, Moore SA, Mathews KS, Darbro BW, Wallrath LL (2024). The influence of genetic variation in CCDC78 on LMNA-associated skeletal muscle disease. Int. J. Mol. Sci. 25(9):4930 DO1:10.3390/ijms25094930
  • Mayer SK, Christensen QH, McCoy-Munger H, Drack AV, Wallrath LL. N-acetyl cysteine alleviates retinal defects in Drosophila models of SNRNP200-associated retinitis pigmentosa. (In preparation)
  • Herndon ME, Ayers M, Gibson-Corley KN, Wendt MK, Wallrath LL, Henry MD, Stipp CS (2024). The highly metastatic 4T1 breast carcinoma model possesses feature of a hybrid epithelial/mesenchymal phenotype. Dis Model Merc. 17 (9). PMCID: PMC11391819
  • Wallace M, Zahr H, Perati CD, Johnson LE, Gacita AM, Lai S, Wallrath LL, Benjamin IJ, McNally EM, Kirby TJ, Lammerding J (2023). Nuclear damage in LMNA mutant iPSC-derived cardiomyocytes is associated with impaired lamin localization to the nuclear envelop. Mol. Biol. Cell. mbcE21100527. DOI: 10.1091/mbc.E21-10-0527 PMID: 37585285
  • Walker SG, Langland CJ, Viles J, Hecker LA, Wallrath LL (2023). Drosophila models reveal properties of mutant lamins that give rise to distinct diseases”. Cells, 12: 1142 DOI: 10.3390/cells12081142 PMCID: PMC10136830
  • Shaw NM, Rios-Monterrosa JL, Fedorchak GR, Ketterer MR, Coombs GS, Lammerding J, Wallrath LL (2022). Effects of mutant lamins on nucleo-cytoskeletal coupling in Drosophila models of LMNA muscular dystrophy. Front Cell Dev Biol. 2022;10:934586. doi: 10.3389/fcell.2022.934586. eCollection 2022. PubMed PMID: 36120560; PubMed Central PMCID: PMC9471154.
  • Wallrath LL, Rodriguez-Tirado F, Geyer PK (2022). Shining Light on the Dark Side of the Genome. Cells. 2022 Jan 19;11(3). doi: 10.3390/cells11030330. Review. PubMed PMID: 35159140; PubMed Central PMCID: PMC8834555.
  • Coombs GS, Rios-Monterrosa JL, Lai S, Dai Q, Goll AC, Ketterer MR, Valdes MF, Uche N, Benjamin IJ, Wallrath LL (2021). Modulation of muscle redox and protein aggregation reduces lethality cause by mutant lamins. Redox Biol. 48:102196 doi:10.1016/j.redox.2021.102196